Beaumont health system biobank: a multidisciplinary biorepository and translational research facility.

The Beaumont BioBank model is a multidisciplinary facility that is designed to provide access and opportunity for research-minded clinicians to become involved in research without the need for their own research infrastructure, thus increasing the research effort across the Health System. We describe a biobank model that works primarily in operating rooms for tissue collection and utilizes a generic consent process to facilitate rapid and accurate collection of biospecimens. The model combines both a biorepository that collects specimens based on clinical questions and also a translational research facility that undertakes biomarker-based research on those specimens in a seamless and efficient process. We believe that the Beaumont BioBank model would be readily applicable and reproducible in other academic healthcare systems.

[1]  M. Hansson The need to downregulate: a minimal ethical framework for biobank research. , 2011, Methods in molecular biology.

[2]  Anne Cambon-Thomsen,et al.  Tracing biological collections: between books and clinical trials. , 2008, JAMA.

[3]  G. Wilson,et al.  SPIN: Development of sample-specific protein integrity numbers as an index of biospecimen quality. , 2013, Biopreservation and biobanking.

[4]  Kathy L. Hudson Genomics, Health Care, and Society , 2012 .

[5]  K. Hoeyer,et al.  Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research , 2004, Scandinavian journal of public health.

[6]  G. Wilson,et al.  Gene Expression Changes Associated With the Progression of Intraductal Papillary Mucinous Neoplasms , 2012, Pancreas.

[7]  G. Wilson,et al.  Isolation and genomic characterization of stem cells in head and neck cancer , 2013, Head & neck.

[8]  Fay Betsou,et al.  Biobanking for better healthcare , 2008, Molecular oncology.

[9]  K. Weinfurt,et al.  Developing a Simplified Consent Form for Biobanking , 2010, PloS one.

[10]  Joakim Dillner,et al.  Should donors be allowed to give broad consent to future biobank research? , 2006, The Lancet. Oncology.

[11]  S. Niemeyer,et al.  Informed consent in biobank research: a deliberative approach to the debate. , 2009, Social science & medicine.

[12]  G. Wilson,et al.  SELDI-TOF-MS Serum Profiling Reveals Predictors of Cardiac MRI Changes in Marathon Runners , 2012, International journal of proteomics.

[13]  Robert E. Hewitt,et al.  Biobanking: the foundation of personalized medicine , 2011, Current opinion in oncology.

[14]  Jim Vaught,et al.  The evolution of biobanking best practices. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[15]  Lucilla Lecchi,et al.  Banking together , 2008, EMBO reports.

[16]  A. Guttmacher,et al.  Genomics, Health Care, and Society , 2011 .

[17]  Pierre Hainaut,et al.  Biobanking in a fast moving world: an international perspective. , 2011, Journal of the National Cancer Institute. Monographs.

[18]  B Hofmann,et al.  Broadening consent—and diluting ethics? , 2009, Journal of Medical Ethics.